dc.contributor.author | SHERLA FEBRIANY | |
dc.date.accessioned | 2013-12-03T04:47:40Z | |
dc.date.available | 2013-12-03T04:47:40Z | |
dc.date.issued | 2013-12-03 | |
dc.identifier.nim | NIM082210101073 | |
dc.identifier.uri | http://repository.unej.ac.id/handle/123456789/2865 | |
dc.description.abstract | 5-fluorouracil is an antineoplastic agent that used for treating solid tumors
such as breast, colorectal and gastric cancers. However, this product still show
saveral side effects. A new compound of 5-fluorouracil derivative has been
synthesized by two step reaction. The first step is the alkylation reaction between 5-
fluorouracil with formaldehyde to produce 1-hydroxymethyl-5-fluorouracil. The
second step is the esterification reaction between 1-hydroxymethyl-5-fluorouracil
with 2-chlorobenzoylchloride to give the target compound, 1-(2-
chlorobenzoyloxymethyl)-5-fluorouracil with 6 hours reaction time. This compound
has been purified using Column Chromatography. And then, the isolate was
characterized and identified using FTIR and 1H-NMR. The product is a yellowish
white chrystalline and has melting range about 193-1940C. FTIR and 1H-NMR
spectrum showed that 1-(2-chlorobenzoyloxymethyl)-5-fluorouracil was successfully
synthesized with percent yield 1,984%. | en_US |
dc.relation.ispartofseries | 082210101073; | |
dc.subject | 5-fluorouracil 1-2-chlorobenzoyloxymethyl-5-fluorouracil anticancer synthesis | en_US |
dc.title | SINTESIS 1-(2-KLOROBENZOILOKSIMETIL)-5-FLUOROURASIL SEBAGAI UPAYA PENGEMBANGAN OBAT ANTIKANKER | en_US |
dc.type | Other | en_US |